Skip to main content
News Archive

Japan’s Takeda clinches $62 billion Shire deal as pharma M&A rolls on – Reuters

By May 14, 2018May 22nd, 2025No Comments

takeda-pharma-logo

Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($62 billion) on Tuesday, the biggest yet in a wave of deals sweeping the drugs industry.

{iframe}https://www.reuters.com/article/us-shire-m-a-takeda/japans-takeda-agrees-62-billion-takeover-of-shire-idUSKBN1I90IC{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.